Swissmedic publishes Information concerning an official Warning from Brazil regarding Falsified Medicinal Product
Recommendation
Wednesday, 18 February 2026 9 .00 - 17.30 h
How to Audit Logistics Service Providers
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The Swissmedic has been informed by the Brazilian Health Regulatory Agency ANVISA that Brazil has suspended all imports of medicinal products from three Turkish wholesalers. The reason for this is the export of falsified units from Turkey to Brazil. One of the batches was also obtained from Turkey and sold to Brazil by a Swiss wholesaler.
In this regard, an information for Swiss companies was published. The Swissmedic points out that Swiss companies are also not permitted to supply medications obtained from the Turkish wholesalers to Brazil.
The names of the three wholesalers and further information can be found on the website of Swissmedic.
Related GMP News
16.12.2025How Valuable Are Commercial GDP Certificates?
16.12.2025Questions and Answers on Transport and Vehicle Qualification (Part 2)
16.12.2025When is a WDA Required? - Discussion of the ECA GDP Survey Results
11.11.2025Supply Chains in 2035
11.11.2025Questions and Answers on Transport and Vehicle Qualification (Part 1)
14.10.2025MHRA Blog Post: GDP in the Aviation and Marine Sectors